Tag: Antiviral Favipiravir

Favipiravir-Glenmark-Pharma
Glenmark Starts Phase-3 Clinical Trials On Favipiravir For COVID Patients In India

New Delhi: Glenmark Pharmaceuticals said on Tuesday that it has initiated phase – three clinical trials on antiviral Favipiravir for COVID-19 patients in India. COVID-19 patients from over 10 leading government and private hospitals in India are being enrolled for the study. The trial completion and study results are expected by July-August this year. Glenmark […]

  • Saturday, 17 April 2021
scrollToTop